Orphan neuropeptide NocII, a putative pronociceptin maturation product, stimulates locomotion in mice.
NocII is a heptadecapeptide whose sequence lies immediately downstream of nociceptin, the newly discovered natural agonist of the ORL1 receptor, in pronociceptin, nociceptin's precursor polypeptide. Since the sequence of NocII is framed by putative convertase excision sites and it totally conserved across murine and human species, we have sought to determine whether this orphan neuropeptide might by physiologically significant, i.e. endowed with central biological activity in vivo. Intracerebroventricular administration of 10 and 100 ng of NocII increased locomotion in mice. However, unlike nociceptin, which stimulates both the horizontal and vertical (rearing) components of locomotion, NocII affected only the horizontal component. The motor stimulant action of NocII appears to depend largely on dopamine transmission since it is totally reversed by the D1 or the D2 dopamine receptor antagonists SCH 23390 and haloperidol. NocII does not modify the number of explored holes in the hole board test, indicating that, unlike nociceptin, the orphan peptide does not affect exploratory behavior in mice.
Florin
S
S
Unité de Neuropsychopharmacologie Expérimentale, CNRS URA 1969, Faculté de Médecine et de Pharmacie de Rouen, Saint Etienne du Rouvray, France.
Suaudeau
C
C
Meunier
J C
JC
Costentin
J
J
D000595:Amino Acid Sequence; D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D017124:Conserved Sequence; D018492:Dopamine Antagonists / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005106:Exploratory Behavior / Q000187:drug effects*; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D008297:Male; D051379:Mice; D008969:Molecular Sequence Data; D009043:Motor Activity / Q000187:drug effects*; D009479:Neuropeptides / Q000737:chemistry / Q000494:pharmacology*; D018847:Opioid Peptides / Q000494:pharmacology*; D017447:Receptors, Dopamine D1 / Q000502:physiology; D017448:Receptors, Dopamine D2 / Q000502:physiology; D011957:Receptors, Opioid / Q000819:agonists; D000097629:Nociceptin
D001552:Benzazepines; D018492:Dopamine Antagonists; D006220:Haloperidol; D009479:Neuropeptides; D018847:Opioid Peptides; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D011957:Receptors, Opioid; D000097629:Nociceptin; C106428:NocII neuropeptide